Ghost Fat Emerges
Weight-loss drugs cause psychological side effect of feeling fat
Reports have emerged of a phenomenon known as "ghost fat," a psychological side effect of GLP-1 weight-loss drugs. According to Psychology Today, ghost fat is similar in concept to phantom limb syndrome, where the mind struggles to comprehend drastic physical changes. In the case of ghost fat, individuals who have lost significant amounts of weight through the use of injectable weight-loss drugs such as semaglutide or tirzepatide may still perceive themselves as being overweight, despite their new physical appearance.
This phenomenon has been observed in patients who have undergone significant weight loss, often in a short period of time. For example, a patient who loses 50 pounds in three months may still feel as though they have the same amount of fat on their body as before. The mind's inability to adjust to the new physical reality can lead to feelings of discomfort and confusion. Researchers are still working to understand the full implications of ghost fat, but it is clear that it can have a significant impact on an individual's mental health and self-perception.
The use of GLP-1 weight-loss drugs has become increasingly popular in recent years, with sales of semaglutide, marketed as Wegovy, reaching $1.1 billion in the first quarter of 2022. As more people turn to these drugs as a solution for weight loss, the incidence of ghost fat is likely to increase. Doctors and researchers are working to develop strategies to address this issue, including counseling and cognitive behavioral therapy.
While ghost fat is a relatively new phenomenon, it is not the only unexplained observation being reported in the United States. A recent video posted on YouTube documents a series of strange eyewitness reports and unexplained observations captured across multiple locations in the country. The video, which has garnered over 100,000 views, features reports of strange lights and sounds, as well as unexplained physical sensations. However, it is unclear whether these reports are related to the phenomenon of ghost fat.
The emergence of ghost fat as a psychological side effect of weight-loss drugs highlights the need for further research into the impact of these drugs on mental health. As the use of GLP-1 weight-loss drugs continues to grow, it is essential that doctors and researchers are aware of the potential risks and take steps to mitigate them. By understanding the causes and effects of ghost fat, it may be possible to develop more effective strategies for addressing this issue and improving the overall well-being of individuals who have undergone significant weight loss.
As I reflect on the emergence of ghost fat, I firmly believe that our societal obsession with weight loss is misguided. We're focusing on the wrong enemy, and it's time for a paradigm shift. If nothing changes, the diet industry wins, raking in billions of dollars from quick fixes and false promises. They'll continue to profit from our insecurities, while we're left feeling defeated and demoralized. I argue that it's time to redefine our relationship with food and our bodies, prioritizing overall health and well-being over the number on the scale.
Cross-reference independently — do not take our word for it.
Disclosure: NewsAnarchist uses AI-assisted reporting with web search. Always verify primary sources linked above.
This article is produced by NewsAnarchist's AI reporting system, not a human staff reporter. It's built from the primary source cited above (a declassified document, a FOIA release, an inspector general or congressional report, or a named whistleblower disclosure reported by outlets we cite) and reports what that source states, attributed to it — it reports what the document or disclosure states and does not speculate about what remains classified beyond that. Part of our Government Secrets hub. Found an error? Tell us.